The store will not work correctly when cookies are disabled.
4-Acetamido-5-cyclopentanecarboxamido-2-fluoro benzoic acid
ID: ALA541257
PubChem CID: 45273487
Max Phase: Preclinical
Molecular Formula: C15H17FN2O4
Molecular Weight: 308.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)Nc1cc(F)c(C(=O)O)cc1NC(=O)C1CCCC1
Standard InChI: InChI=1S/C15H17FN2O4/c1-8(19)17-13-7-11(16)10(15(21)22)6-12(13)18-14(20)9-4-2-3-5-9/h6-7,9H,2-5H2,1H3,(H,17,19)(H,18,20)(H,21,22)
Standard InChI Key: ZWVFCXAGLPMNES-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
7.2426 2.6255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5281 2.2130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5281 1.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2426 0.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9570 1.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9570 2.2130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6715 2.6255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6715 3.4505 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3860 2.2130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2426 3.4505 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.8136 0.9755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8136 0.1505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5281 -0.2620 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0991 -0.2620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2426 0.1505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9570 -0.2620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6715 0.1505 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9570 -1.0870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6245 -1.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3695 -2.3565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5445 -2.3565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2896 -1.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 11 1 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
12 14 1 0
6 7 1 0
4 15 1 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
18 19 1 0
7 9 2 0
4 5 1 0
1 10 1 0
2 3 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
16 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.31 | Molecular Weight (Monoisotopic): 308.1172 | AlogP: 2.61 | #Rotatable Bonds: 4 |
Polar Surface Area: 95.50 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.25 | CX Basic pKa: ┄ | CX LogP: 1.92 | CX LogD: -1.52 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -1.38 |
References
1. Magesh S, Savita V, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M.. (2009) Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids., 17 (13): [PMID:19450982] [10.1016/j.bmc.2009.04.065] |